相关实验视频
Updated: Jan 30, 2026
09:20
Intradermal Inoculation of Mycobacterium avium in the Mouse Ear
Published on: July 3, 2025
1.3K
针对M. avium肺病的治疗策略
Rannvá Winther1, Søren Sperling2,3, Andreas Fløe2,3
1Department of Internal Medicine, Horsens Regional Hospital, Horsens, Denmark.
Breathe (Sheffield, England)
|January 29, 2026
概括
针对非结核性真菌菌菌感染的最佳基于宏类药物组合尚不清楚. 研究表明,每日治疗和间歇性治疗方案具有相似的耐受性,两种药物选择可能对Mycobacterium avium复合体是可行的.
科学领域:
- 传染性疾病 传染性疾病
- 微生物学 微生物学
- 临床药理学 临床药理学
背景情况:
- 麦克罗利德对于治疗非结核性真菌菌 (NTM) 是至关重要的.
- 针对NTM感染,特别是Mycobacterium avium复合体 (MAC) 的最佳药物组合和治疗持续时间仍然不确定.
- 现有的研究需要进一步研究治疗疗效和患者耐受性.
研究的目的:
- 评估不同治疗方案对Mycobacterium avium复合体 (MAC) 感染的疗效和耐受性.
- 为了比较间歇性与每日基于宏类的疗法.
- 评估含有克洛法齐明的疗法与含有利芬素的疗法之间的非劣势.
主要方法:
- 两个随机对照试验 (Nagawawa等人,Zweijpfenning等人). 研究了各种治疗方案.
- 一项试验比较了间歇性与每日三种药物宏类基疗法.
- 另一项试验比较了乙胺醇和宏类药物与利法素或克洛法西明.
- 一个元分析 (Nguyen等人). 综合了关于治疗策略的发现.
主要成果:
- 与每日治疗相比,间歇性治疗没有显示明显优异的耐受性.
- 发现包括克洛法齐明,乙墨托尔和宏类药物的治疗方案与含有里法辛的治疗方案相比,效果不逊色.
- 一项元分析表明,两种药物治疗方案可能是MAC感染的可行治疗选择.
结论:
- 间歇性基于宏类的治疗方案的治疗耐受性与每日治疗相当.
- 基于克洛法齐明的疗法是用于治疗MAC的基于利法素的疗法的一个可行的替代方案.
- 两种药物治疗方案显示出作为管理MAC感染的有效策略的潜力,需要进一步的临床考虑.
更多相关视频
相关概念视频
01:24Treatment Strategies for Psychological Disorders
769
Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
769
01:24Parkinson's Disease: Treatment
1.2K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
01:22Alzheimer's Disease: Treatment
944
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
944
01:24Chronic Obstructive Pulmonary Disease
2.5K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.5K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
3.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.7K
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.2K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.2K